FDG positron emission tomography for evaluating esophageal cancer.  [electronic resource] 

 -  Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel  Dec 2001 
 - 13-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blue Cross Blue Shield Insurance Plans<br/>Esophageal Neoplasms--diagnostic imaging<br/>Humans<br/>Insurance Coverage<br/>Neoplasm Staging--instrumentation<br/>Sensitivity and Specificity<br/>Technology Assessment, Biomedical<br/>Tomography, Emission-Computed--instrumentation<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>United States<br/>United States Food and Drug Administration